The non-hormonal therapies market is projected to be worth USD 10.9 billion in 2030 – ChattTenn Sports

Roots Analysis has announced the addition of “Non-hormonal Therapies for Women’s Health Market ” report to its list of offerings.


In pursuit of an advantageous and risk-free prospect to hormonal therapies, the success of 21 approved non-hormonal therapies has resulted in a surge in the interest of drug developers in this rapidly evolving domain. As a result, the non-hormonal therapies market is abuzz with activity, in terms of partnerships and funding initiatives.


To order this 225+ page report, which features 92+ figures and 154+ tables, please visit


Key Market Insights


Around 55 non-hormonal therapies are currently being developed across different stages

Apart from 21 approved products, close to 58% of the aforementioned candidates are being evaluated in clinical stages of development, with 2% of therapies in preclinical stages. It is worth mentioning that more than 80% of such drugs are small molecules. Further, majority of the therapies are being developed for the treatment of endometriosis (19%).


Over 64% of the non-hormonal therapy developers are based in North America

Interestingly, within the aforementioned region, majority of the players (21) are based in the US, which is considered a prominent R&D hub for advanced therapeutic products. Moreover, the current market is dominated by the presence of small players and very large firms, respectively.


220+ non-hormonal therapy focused clinical trials have been registered, worldwide

The clinical research activity, in terms of number of trials registered, is reported to have increased at a CAGR of 19% during the period 2015-2019. Of the total number of trials, close to 83% have already been completed, while 15% studies are presently active.



To request a sample copy / brochure of this report, please visit


Key Questions Answered

  • Who are the leading industry players engaged in the development of non-hormonal therapies?
  • How many non-hormonal therapy candidates are present in the current development pipeline? Which key women’s health related disease indications are targeted by such products?
  • Which commercialization strategies are most commonly adopted by non-hormonal therapy developers, across different stages of product development?
  • Which partnership models are commonly adopted by stakeholders engaged in this domain?
  • What are the key value drivers of the merger and acquisition activity in the non-hormonal therapies industry?
  • Who are the key stakeholders that have actively made investments in the non-hormonal therapy domain?
  • How is the current and future market opportunity likely to be distributed across key market segments?


The USD 10.5+ billion (by 2030) financial opportunity associated with non-hormonal therapies market has been analyzed across the following segments:


  • Target Indication
  • Bacterial vaginosis
  • Contraception
  • Endometriosis
  • Postmenopausal Osteoporosis
  • Uterine fibroids
  • Vaginitis
  • Others


  • Type of Molecule
  • Biologics
  • Small molecules


  • Route of Administration
  • Intramuscular
  • Intravaginal
  • Intravenous
  • Oral
  • Subcutaneous
  • Topical
  • Transdermal
  • Others


  • Key Geographical Regions
  • North America
  • Europe
  • Asia-Pacific


You may also be interested in the following titles:

  1. RNA Targeting Small Molecules Therapeutics Market: Industry Trends and Global Forecasts, 2023-2030
  2. Top Selling Biologics Market: Industry Trends and Global Forecasts, 2023-2030
  3. Peptide Therapeutics Market: Industry Trends and Global Forecasts, 2023-2030



Ben Johnson

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]



The global Bio-organic Fertilizer market was valued at million in 2023 and is projected to reach US$ million by 2028,…


The global Probiotics in Feed market was valued at million in 2023 and is projected to reach US$ million by…


The global Liquid Crystal Polyester market was valued at 1193.6 million in 2023 and is projected to reach US$ 1581.9…


The global Powder Coating Resin market was valued at million in 2023 and is projected to reach US$ million by…


The global Medical Grade Elastomeric Materials market was valued at million in 2023 and is projected to reach US$ million…


Dodecylphenol is a dense, viscous, light yellow liquid with a characteristic phenolic odour. It is a mixture of isomers containing…